J

Japan Tissue Engineering Co Ltd
TSE:7774

Watchlist Manager
Japan Tissue Engineering Co Ltd
TSE:7774
Watchlist
Price: 495 JPY 0.2% Market Closed
Market Cap: 20.1B JPY
Have any thoughts about
Japan Tissue Engineering Co Ltd?
Write Note

Relative Value

The Relative Value of one Japan Tissue Engineering Co Ltd stock under the Base Case scenario is 618.12 JPY. Compared to the current market price of 495 JPY, Japan Tissue Engineering Co Ltd is Undervalued by 20%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
618.12 JPY
Undervaluation 20%
Relative Value
Price
J
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
88
vs Industry
43
Median 3Y
10.4
Median 5Y
10.9
Industry
7.7
Forward
6.8
vs History
vs Industry
0
Median 3Y
-51.2
Median 5Y
-65.8
Industry
22.7
Forward
140
vs History
11
vs Industry
2
Median 3Y
-46.8
Median 5Y
-93.8
Industry
21.6
vs History
11
vs Industry
100
Median 3Y
-32.8
Median 5Y
-65.8
Industry
25.2
vs History
69
vs Industry
19
Median 3Y
3.6
Median 5Y
3.8
Industry
2.5
vs History
88
vs Industry
39
Median 3Y
8.3
Median 5Y
9
Industry
7.7
Forward
5.3
vs History
90
vs Industry
30
Median 3Y
13.7
Median 5Y
15.7
Industry
9
vs History
6
vs Industry
1
Median 3Y
-39
Median 5Y
-65.7
Industry
4.2
Forward
54
vs History
vs Industry
0
Median 3Y
-38.8
Median 5Y
-54.1
Industry
4.1
vs History
11
vs Industry
2
Median 3Y
-37.2
Median 5Y
-71.9
Industry
5.7
vs History
11
vs Industry
100
Median 3Y
-26.1
Median 5Y
-53.3
Industry
3.6
vs History
63
vs Industry
23
Median 3Y
7.1
Median 5Y
7.9
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Japan Tissue Engineering Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Japan Tissue Engineering Co Ltd
TSE:7774
20.1B JPY 8.8 -245.7 222.3 -251
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
JP
J
Japan Tissue Engineering Co Ltd
TSE:7774
Average P/E: 208.3
Negative Multiple: -245.7
699%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
JP
J
Japan Tissue Engineering Co Ltd
TSE:7774
Average EV/EBITDA: 46.5
222.3
414%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
JP
J
Japan Tissue Engineering Co Ltd
TSE:7774
Average EV/EBIT: 22.5
Negative Multiple: -251
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top